Your browser doesn't support javascript.
loading
Patient Reported Outcome Measures in Adults with Fontan Circulatory Failure.
Agorrody, Guillermo; Begun, Isaac; Verma, Subodh; Mazer, C David; Garagiola, Maria Luz; Fernandez-Campos, Beatriz; Acuña, Ronald; Kearney, Katherine; Buckley, Alvan; Dhingra, Nitish K; Ghamarian, Ehsan; Roche, S Lucy; Alonso-Gonzalez, Rafael; Wald, Rachel M.
Afiliação
  • Agorrody G; Toronto Adult Congenital Heart Disease Program, Peter Munk Cardiac Centre, Division of Cardiology, University Health Network, University of Toronto, Toronto, ON M5G 2N2, Canada.
  • Begun I; Toronto Adult Congenital Heart Disease Program, Peter Munk Cardiac Centre, Division of Cardiology, University Health Network, University of Toronto, Toronto, ON M5G 2N2, Canada.
  • Verma S; Division of Cardiac Surgery, Unity Health, St. Michael's Hospital, University of Toronto, 585 University Avenue, Toronto, ON M5G 2N2, Canada.
  • Mazer CD; Department of Anaesthesia, Unity Health, St. Michael's Hospital, University of Toronto, Toronto, ON M5S 1A1, Canada.
  • Garagiola ML; Toronto Adult Congenital Heart Disease Program, Peter Munk Cardiac Centre, Division of Cardiology, University Health Network, University of Toronto, Toronto, ON M5G 2N2, Canada.
  • Fernandez-Campos B; Toronto Adult Congenital Heart Disease Program, Peter Munk Cardiac Centre, Division of Cardiology, University Health Network, University of Toronto, Toronto, ON M5G 2N2, Canada.
  • Acuña R; Toronto Adult Congenital Heart Disease Program, Peter Munk Cardiac Centre, Division of Cardiology, University Health Network, University of Toronto, Toronto, ON M5G 2N2, Canada.
  • Kearney K; Toronto Adult Congenital Heart Disease Program, Peter Munk Cardiac Centre, Division of Cardiology, University Health Network, University of Toronto, Toronto, ON M5G 2N2, Canada.
  • Buckley A; Toronto Adult Congenital Heart Disease Program, Peter Munk Cardiac Centre, Division of Cardiology, University Health Network, University of Toronto, Toronto, ON M5G 2N2, Canada.
  • Dhingra NK; Division of Cardiac Surgery, Unity Health, St. Michael's Hospital, University of Toronto, 585 University Avenue, Toronto, ON M5G 2N2, Canada.
  • Ghamarian E; Applied Health Research Centre, Unity Health, St. Michael's Hospital, University of Toronto, Toronto, ON M5S 1A1, Canada.
  • Roche SL; Toronto Adult Congenital Heart Disease Program, Peter Munk Cardiac Centre, Division of Cardiology, University Health Network, University of Toronto, Toronto, ON M5G 2N2, Canada.
  • Alonso-Gonzalez R; Toronto Adult Congenital Heart Disease Program, Peter Munk Cardiac Centre, Division of Cardiology, University Health Network, University of Toronto, Toronto, ON M5G 2N2, Canada.
  • Wald RM; Toronto Adult Congenital Heart Disease Program, Peter Munk Cardiac Centre, Division of Cardiology, University Health Network, University of Toronto, Toronto, ON M5G 2N2, Canada.
J Clin Med ; 13(14)2024 Jul 17.
Article em En | MEDLINE | ID: mdl-39064214
ABSTRACT

Background:

Patient reported outcomes (PROs) are important measures in acquired heart disease but have not been well defined in Adult Congenital Heart Disease (ACHD). Our aim was to explore the discriminatory capacity of PRO survey tools in Fontan circulatory failure (FCF).

Methods:

Consecutive adults were enrolled from our ambulatory clinics. Inclusion criteria were age ≥18 years, a Fontan circulation or a hemodynamically insignificant shunt lesion, and sufficient cognitive/language abilities to complete PROs. A comprehensive package of PRO measures, designed to assess perceived health-related quality of life (HRQOL) was administered (including the Kansas City Cardiomyopathy Questionnaire [KCCQ-12], EuroQol-5-dimension [EQ5D], Short Form Health Status Survey [SF-12], self-reported New York Heart Association [NYHA] Functional Class, and Specific Activity Scale [SAS]).

Results:

We compared 54 Fontan patients (35 ± 10 years) to 25 simple shunt lesion patients (34 ± 11 years). The KCCQ-12 score was lower in Fontan versus shunt lesion patients (87 [IQR 79, 95] versus 100 [IQR 97, 100], p-value < 0.001). The FCF subgroup was associated with lower KCCQ-12 scores as compared with the non-FCF subgroup (82 [IQR 56, 89] versus 93 [IQR 81, 98], p-value = 0.002). Although the KCCQ-12 had the best discriminatory capacity for determination of FCF of all PRO tools studied (c-statistic 0.75 [CI 0.62, 0.88]), superior FCF discrimination was achieved when the KCCQ-12 was combined with all PRO tools (c-statistic 0.82 [CI 0.71, 0.93]).

Conclusions:

The KCCQ-12 questionnaire demonstrated good discriminatory capacity for the identification of FCF, which was further improved through the addition of complementary PRO tools. Further research will establish the value of PRO tools to guide management strategies in ACHD.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article